Lantheus Holdings, INC Schedule 13D activist filings
Filed when an investor crosses five percent and intends to influence the company — the activist disclosure.
NASDAQ
Lantheus Holdings, Inc. and its subsidiaries have significantly reduced their beneficial ownership in Perspective Therapeutics, Inc., selling over 8.7 million shares.
NASDAQ
Lantheus Holdings, Inc. and its subsidiaries have reported the sale of over 236,000 shares of Perspective Therapeutics, Inc. common stock, reducing their beneficial ownership to 10.0%.
NASDAQ
Lantheus Holdings, through its subsidiaries, has disclosed a significant beneficial ownership of 20.9% in Radiopharm Theranostics Limited, detailing strategic investments and co-development partnerships.